305 research outputs found
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of prior guidelines
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
This is the second of a series of two articles reporting the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of adult patients with ulcerative colitis [UC]. The first article is focused on medical management and the present article addresses medical treatment of acute severe ulcerative colitis [ASUC] and surgical management of medically refractory UC patients, including preoperative optimization, surgical strategies, and technical issues. The article provides advice for a variety of common clinical and surgical conditions. Together, the articles represent an update of the evidence-based recommendations of the ECCO for UC
European evidence based consensus on surgery for ulcerative colitis.
The goal of this consensus initiated by the European Crohn's
and Colitis Organisation (ECCO) was to establish European
consensus guidelines for the surgical treatment of ulcerative
colitis. The strategy to reach the consensus involved several
steps and follows the standard operating procedures for
consensus guidelines of ECCO. An open call for chairs and
participants for this consensus was made (see acknowledgements
and www.ecco-ibd). Participants were selected by
the Guidelines' Committee of ECCO (GuiCom) on the basis of
their publication record and a personal statement
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.sponsorship: This project was initiated, funded, and supported by the European Crohn's and Colitis Organisation. (European Crohn's and Colitis Organisation)status: Publishe
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
This is the second of a series of two articles reporting the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of adult patients with ulcerative colitis [UC]. The first article is focused on medical management, and the present article addresses medical treatment of acute severe ulcerative colitis [ASUC] and surgical management of medically refractory UC patients, including preoperative optimisation, surgical strategies, and technical issues. The article provides advice for a variety of common clinical and surgical conditions. Together, the articles represent an update of the evidence-based recommendations of the ECCO for UC
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
Background and aim: Limited data suggests that pseudomembranes are uncommon in patients with inflammatory bowel disease (IBD) and C. difficile associated disease (CDAD), but the reason for this is unknown.
We aimed to evaluate the rate of pseudomembranes in this population, identify predictive factors for pseudomembranes' presence and assess its clinical impact.
Methods: This was a sub-study of a retrospective European Crohn's & Colitis Organization (ECCO) multi-center study on the outcome of hospitalized IBD patients with C. difficile. The present study included only patients who underwent lower endoscopy during hospitalization, and compared
demographic and clinical parameters in the group of patients with discernable pseudomembranes versus those without.
Results: Out of 155 patients in the original cohort, 93 patients underwent lower endoscopy and constituted the study population. Endoscopic pseudomembranes were found in 12 (13%) of these patients. Patients with pseudomembranes presented more commonly with fever (p=0.02) compared to patients without pseudomembranes. No difference between the two groups was found with respect to the use of immunosuppressant drugs, background demographics or disease
characteristics. Neither was there a difference between the group with or without pseudomembranes in the frequency of severe adverse clinical outcome or in the duration of hospitalization. On multi-variate analysis the presence of fever remained independently associated with the finding of
pseudomembranes (OR 6, 95% CI 1.2–32, p=0.03).
Conclusions: This study documents that hospitalized IBD patients with CDAD have low rate of endoscopic pseudomembranes, which is not accounted for by the use of immunosuppressant drugs. IBD patients with CDAD and discernable pseudomembranes more commonly present with
fever, but their clinical outcome is similar to patients without pseudomembranes.
© 2009 Published by Elsevier B.V. on behalf of European Crohn's and Colitis Organisation
European evidence based consensus on surgery for ulcerative colitis
The goal of this consensus initiated by the European Crohn's and Colitis Organisation (ECCO) was to establish European consensus guidelines for the surgical treatment of ulcerative colitis. The strategy to reach the consensus involved several steps and follows the standard operating procedures for consensus guidelines of ECC
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
This article is the second in a series of two publications on the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of prior ECCO Guidelines
2nd N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn's Disease or Ulcerative Colitis
This is the second Nurse European Crohns and Colitis (N-ECCO) consensus statements document addressing inflammatory bowel disease (IBD) nursing across Europe. N-ECCO continues to be an active member of European Crohns and Colitis Organisation (ECCO), providing education and networking opportunities for nurses across Europe within three designated nurse sessions, N-ECCO Network Meeting, N-ECCO School and the N-ECCO Research Forum, in addition to e-learning and podcast
European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD
This ECCO Topical Review of the European Crohn's and Colitis Organisation [ECCO] focuses on the role of environmental factors with respect to the development of inflammatory bowel disease [IBD] as well as their influence on the course of established IBD. The objective was to reach expert consensus to provide evidence-based guidance for clinical practice.</p
- …
